Tipranks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry now
Expert CenterTop Wall Street AnalystsTop Financial BloggersTop Corporate InsidersTop Hedge Fund ManagersTop Individual InvestorsTop Performing Research Firms
Stock Comparison5g StocksAirline StocksArtificial Intelligence StocksBank StocksBiotech StocksBitcoin StocksBlockchain StocksBlue Chip StocksCannabis StocksCasino StocksChinese StocksCoronavirus Therapeutics StocksCoronavirus Vaccine StocksCryptocurrency StocksCybersecurity StocksElectric Vehicle StocksFAANG StocksGold StocksGrowth StocksHealthcare StocksHigh Dividend StocksHotel StocksLarge Cap StocksMega Cap StocksNFT StocksOil StocksOutdoor Activities StocksRenewable Energy StocksSolar StocksSpace StocksStay-At-Home StocksTech StocksUtility StocksVideo Game StocksVirtual Reality StocksWallStreetBets StocksWork-From-Home Stocks
Capricor Therapeutics (CAPR)
NASDAQ:CAPR
Capricor Therapeutics Stock Analysis & Ratings
Capricor Therapeutics Stock Analysis Overview
Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
ANALYST RATINGS
CONSENSUS
Moderate Buy
Average Price Target : $13.00
BLOGGER OPINIONS
SENTIMENT
N/A
Currently Not Enough Data Available
HEDGE FUND ACTIVITY
TREND
▼ Decreased
By 1.2M Shares Last Quarter.
INSIDER ACTIVITY
TREND
▲ Bought Shares
Worth $43.9K over the Last 3 Months
TIPRANKS INVESTORS
SENTIMENT
Very Positive
Last 7 Days ▲5.3% Last 30 Days ▲1.8%
NEWS SENTIMENT
LAST 7 DAYS
Bullish
Bullish 100% Bearish 0%
TECHNICALS
SMA
Negative
20 days / 200 days
MOMENTUM
-55.32%
12 Months Change
FUNDAMENTALS
RETURN ON EQUITY
-53.65%
Trailing 12 Months
ASSET GROWTH
19.10%
Trailing 12 Months
CAPR Stock Stats
Previous Close$2.83
Open$2.96
Bid3.44 x 80
Ask3.52 x 344
Today’s Range$2.88 - $3.56
52-Week Range$2.56 - $8.40
Volume7.76M
Average Volume614.10K
Market Cap$83.07M
Beta6.16
P/E Ratio-4.2
EPS-0.81
Earnings DateMar 16, 2022
1Y Price Target$13.00
Company Description
Capricor Therapeutics
Financials
P/E Ratio Range
The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.
Capricor Therapeutics News
CAPR FAQ
What was Capricor Therapeutics’s price range in the past 12 months?
Capricor Therapeutics lowest stock price was $2.56 and its highest was $8.40 in the past 12 months.
What is Capricor Therapeutics’s market cap?
Capricor Therapeutics’s market cap is $83.07M.
What is Capricor Therapeutics’s price target?
The average price target for Capricor Therapeutics is $13.00. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $14.00 ,the lowest forecast is $12.00. The average price target represents 277.91% Increase from the current price of $3.44.
The highest analyst price target is $14.00 ,the lowest forecast is $12.00. The average price target represents 277.91% Increase from the current price of $3.44.
What do analysts say about Capricor Therapeutics?
Capricor Therapeutics’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
When is Capricor Therapeutics’s upcoming earnings report date?
Capricor Therapeutics’s upcoming earnings report date is Mar 16, 2022 which is in 49 days.
How were Capricor Therapeutics’s earnings last quarter?
Capricor Therapeutics released its earnings results on Nov 09, 2021. The company reported -$0.17 earnings per share for the quarter, beating the consensus estimate of -$0.23 by $0.06.
Is Capricor Therapeutics overvalued?
According to Wall Street analysts Capricor Therapeutics’s price is currently Undervalued.
Does Capricor Therapeutics pay dividends?
Capricor Therapeutics does not currently pay dividends.
What is Capricor Therapeutics’s EPS estimate?
Capricor Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Capricor Therapeutics have?
Capricor Therapeutics has 24,150,000 shares outstanding.
What happened to Capricor Therapeutics’s price movement after its last earnings report?
Capricor Therapeutics reported an EPS of -$0.17 in its last earnings report, beating expectations of -$0.23. Following the earnings report the stock price went down -4.62%.
Which hedge fund is a major shareholder of Capricor Therapeutics?
Among the largest hedge funds holding Capricor Therapeutics’s share is Oracle Investment Management Inc. It holds Capricor Therapeutics’s shares valued at N/A.